Summit Trail Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.06M Buy
34,772
+12,749
+58% +$1.12M 0.05% 182
2025
Q1
$1.99M Buy
22,023
+4,129
+23% +$374K 0.07% 96
2024
Q4
$1.44M Buy
17,894
+3,497
+24% +$282K 0.05% 106
2024
Q3
$1.31M Sell
14,397
-415
-3% -$37.6K 0.03% 220
2024
Q2
$1.18M Buy
14,812
+169
+1% +$13.4K 0.03% 214
2024
Q1
$1.29M Buy
14,643
+3,451
+31% +$303K 0.03% 178
2023
Q4
$930K Sell
11,192
-615
-5% -$51.1K 0.03% 190
2023
Q3
$933K Sell
11,807
-1,142
-9% -$90.3K 0.03% 174
2023
Q2
$1.15M Buy
12,949
+4,413
+52% +$392K 0.04% 150
2023
Q1
$694K Buy
8,536
+2,049
+32% +$167K 0.03% 176
2022
Q4
$508K Buy
6,487
+255
+4% +$20K 0.02% 183
2022
Q3
$507K Sell
6,232
-130
-2% -$10.6K 0.03% 177
2022
Q2
$575K Buy
6,362
+1,652
+35% +$149K 0.04% 167
2022
Q1
$525K Buy
+4,710
New +$525K 0.04% 162
2019
Q1
Sell
-2,741
Closed -$250K 119
2018
Q4
$250K Sell
2,741
-6,205
-69% -$566K 0.09% 89
2018
Q3
$884K Buy
8,946
+3,345
+60% +$331K 0.2% 66
2018
Q2
$480K Sell
5,601
-9,759
-64% -$836K 0.17% 73
2018
Q1
$819K Buy
15,360
+2,586
+20% +$138K 0.14% 156
2017
Q4
$1.08M Buy
+12,774
New +$1.08M 0.14% 147